Molina Healthcare (MOH) is trading higher as investors position ahead of the company’s next catalyst: first-quarter 2026 results, due after the market close on Wednesday, April 22, 2026, with a conference call the next morning. The stock has been under heavy pressure since the company reset expectations for 2026 profitability amid elevated medical costs, so even modest signs of stabilization can drive sharp day-to-day moves into earnings. (investors.molinahealthcare.com)

Management has recently emphasized that it intends to reaffirm its 2026 outlook (GAAP diluted EPS of at least $3.20 and adjusted diluted EPS of at least $5.00) in investor meetings, which has helped anchor expectations into the April earnings print. With the report arriving tomorrow after the close (April 22), today’s ~3% move is consistent with pre-earnings repositioning rather than a single contract headline. (tipranks.com)

Molina’s earlier guidance reset highlighted higher medical cost trends and near-term drags tied to contract dynamics and Medicare-related issues, leaving the market focused on whether utilization is stabilizing and whether margins can recover. Recent analyst commentary into the quarter has stressed the same variables—medical care ratios, membership/premium trends, and the credibility of the 2026 recovery path—keeping the stock sensitive to any incremental change in expectations. (zacks.com)

The key questions into the April 22 release are whether Molina can show improved cost trend visibility versus late 2025/early 2026, whether it maintains or adjusts its 2026 EPS floor, and whether it provides updated color on contract ramp timing and the pathway to embedded earnings realization. The company also has additional scheduled investor touchpoints in early May, which can extend the news cycle beyond the earnings call. (investors.molinahealthcare.com)